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Sinus computed tomography findings in 
patients with COVID-19
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 ❚ ABSTRACT
Objective: To analyze computed tomography scans of paranasal sinuses of a series of patients 
with coronavirus disease 2019, and correlate the findings with the disease. Methods: Computed 
tomography scans of 95 adult patients who underwent a polymerase chain reaction test for severe 
acute respiratory syndrome coronavirus 2 were analyzed. Clinical data were obtained from patients’ 
records and telephone calls. Paranasal sinus opacification was graded and compared according to 
severe acute respiratory syndrome coronavirus 2 positivity. Results: Of the patients 28 (29.5%) tested 
positive for severe acute respiratory syndrome coronavirus 2  (median age 52 [range 26-95] years) and 
67 were negative (median age 50 [range 18-95] years). Mucosal thickening was present in 97.4% 
of maxillary sinuses, 80% of anterior ethmoid air cells, 75.3% of posterior ethmoid air cells, 74.7% 
of frontal sinuses, and 66.3% of sphenoid sinuses. Minimal or mild mucosal thickening (score 1) 
and normally aerated sinuses (score 0) corresponded to 71.4% and 21.3% of all paranasal sinuses, 
respectively. The mean score of each paranasal sinus among severe acute respiratory syndrome 
coronavirus 2 positive and negative patients was 0.85±0.27 and 0.87±0.38, respectively (p=0.74). 
Median paranasal sinus opacification score among severe acute respiratory syndrome coronavirus 
2 positive patients was 9 (interquartile range 8-10) compared to 9 (interquartile range 5-10) in 
negative patients (p=0.89). There was no difference in mean score adjusted for age and sex. 
Nasal congestion was more frequent in severe acute respiratory syndrome coronavirus 2 positive 
than negative patients (p=0.05). Conclusion: Severe acute respiratory syndrome coronavirus 2 
infection was associated with patient recall of nasal congestion, but showed no correlation with 
opacification of paranasal sinuses.
Keywords: Tomography, X-Ray computed; Coronavirus infections; COVID-19; Betacoronavirus; 
SARS-CoV-2; Paranasal sinuses; Rhinitis
 ❚ RESUMO
Objetivo: Analisar imagens de tomografia computadorizada de seios paranasais de pacientes 
com a doença por coronavírus 2019, e correlacionar os achados com a doença. Métodos: Foram 
analisadas imagens de tomografia computadorizada de 95 pacientes submetidos a teste de 
reação em cadeia da polimerase para coronavírus 2 da síndrome respiratória aguda grave. Os 
dados clínicos foram obtidos por meio dos prontuários dos pacientes e de ligações telefônicas. A 
opacificação dos seios paranasais foi graduada e comparada entre pacientes positivos e negativos 
para coronavírus 2 da síndrome respiratória aguda grave. Resultados: Vinte e oito (29,5%) dos 
pacientes tiveram resultado positivo para coronavírus 2 da síndrome respiratória aguda grave 
(idade mediana de 52 [26-95] anos) e 67, resultado negativo (idade mediana de 50 [18-95] anos). O 
espessamento mucoso estava presente em 97,4% dos seios maxilares, 80% das células etmoidais 
anteriores, 75,3% das células etmoidais posteriores, 74,7% dos seios frontais e em 66,3% dos seios 
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esfenoidais. Mínimo ou discreto espessamento mucoso (pontuação 
1) e seios com aeração normal (pontuação 0) corresponderam a 
71,4% e 21,3% de todos os seios paranasais, respectivamente. 
A nota média de cada seio paranasal entre pacientes positivos e 
negativos para coronavírus 2 da síndrome respiratória aguda grave 
foi de 0,85±0,27 e 0,87±0,38, respectivamente (p=0,74). A nota 
mediana de opacificação dos seios paranasais entre pacientes 
positivos para coronavírus 2 da síndrome respiratória aguda grave 
foi de 9 (intervalo interquartil de 8 a 10), comparada a 9 (intervalo 
interquartil de 5 a 10) em pacientes negativos (p=0,89). Não houve 
diferença na nota média ajustada para idade e sexo. A congestão 
nasal foi mais frequente em pacientes positivos para coronavírus 2 
da síndrome respiratória aguda grave que naqueles com resultados 
negativos (p=0,05). Conclusão: A infecção pelo coronavírus 2 da 
síndrome respiratória aguda grave apresentou associação com 
congestão nasal, mas não mostrou correlação com espessamento 
mucoso dos seios paranasais.
Descritores: Tomografia computadorizada por raios X; Infecções 
por coronavírus; COVID-19; Betacoronavírus; SARS-CoV-2; Seios 
paranasais; Rinite 
 ❚ INTRODUCTION
Coronavirus disease 2019 (COVID-19) caused by 
severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) spread rapidly worldwide from its 
origin in China. Upper airway symptoms, such as 
nasal congestion and rhinorrhea, have been reported 
to be relatively rare when compared with pulmonary 
symptoms,(1-3) and few studies have addressed the effects 
of SARS-CoV-2 infection on the paranasal sinuses using 
computed tomography (CT) scans.(4-6) 
 ❚ OBJECTIVE
To analyze computed tomography scans of paranasal 
sinuses of a series of patients with coronavirus disease 
2019, and correlate the findings with the disease.
 ❚METHODS
Patients
All patients undergoing paranasal sinus CT scans in 
our organization and who were tested for SARS-CoV-2 
over an 11-week period, from March 14 to May 30, 
2020, were eligible for inclusion. Emergency room, 
inpatients, and outpatients were included. Patient 
clinical and image data were reviewed retrospectively. 
All SARS-CoV-2 positive and a random sample of 30 
SARS-CoV-2 negative patients were called by 
telephone. Those who responded were asked to 
recall whether they had anosmia, hyposmia and nasal 
congestion at the time of the CT scans. Severe acute 
respiratory syndrome coronavirus 2 positivity was 
determined from nasopharyngeal swabs collected for 
each patient and tested for SARS-CoV-2 using a real-
time reverse transcription polymerase chain reaction 
(RT-PCR) assay.
The exclusion criteria were patients under 18 years 
of age; recent sinonasal surgery; sinonasal tumor; acute 
facial trauma.
Imaging analysis
All patients underwent paranasal sinus CT scans (16- to 
640-slice CT scanners: Aquilion Prime™, Aquilion 
One™, Aquilion One Vision™, Toshiba Medical Systems 
Corporation, Ltda, Japan; PET-CT Discovery 600, GE 
Medical Systems, USA; and SOMATOM® Definition, 
Siemens, Germany) with the following parameters: 
35mA, 120kV, 0.5 to 0.6mm slice thickness. All CT 
images were independently analyzed by two head and 
neck radiologists, with 5 and 12 years of experience, 
who were blinded to RT-PCR results. Disagreements 
were resolved by consensus.
Maxillary, anterior ethmoid, posterior ethmoid, 
sphenoid, and frontal paranasal sinuses were assessed 
for opacification. Sinuses with mucosal thickening 
<1mm were considered normal. Each paranasal sinus 
was graded according to a modified Lund-Mackay 
score as no opacification (score 0); opacification 1% 
to 50% (score 1); opacification 51% to 99% (score 2), 
and complete opacification (score 3). The presence of 
air-fluid level was also evaluated. 
Statistical analysis
Frequencies and median scores in SARS-CoV-2 positive 
and negative patients were compared using χ2 or Fisher’s 
exact, Kruskal-Wallis, and Student’s t tests (alpha 
<0.05), while differences in total opacification score 
and olfactory obstruction, adjusted for age and sex, were 
quantified by logistic and linear regression, respectively.
This study was approved by the Ethics Committee 
of Hospital Israelita Albert Einstein (HIAE), CAAE: 
31014720.9.0000.0071, number 4.002.511. The need for 
written patient consent was waived.
 ❚ RESULTS
A total of 95 patients were included, of whom 28 
(29.5%) were SARS-CoV-2 RT-PCR-positive and 67 
(70.5%) were negative. The median age was 50 (range 
18 to 95) years. There were 53 men (55.8%). The two 
groups did not differ by age or sex (Table 1).
Sinus computed tomography findings in patients with COVID-19
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Among the 17/28 SARS-CoV-2 positive and 23/30 
SARS-CoV-2 negative patients who responded to 
telephone follow-up, anosmia/hyposmia was recalled 
by 7/17 (41%) positive and 0/23 negative patients 
(p=0.001). Nasal congestion was recalled by 7/17 (41%) 
SARS-CoV-2 positive and by 1/23 (4.3%) SARS-Cov-2 
negative patients (p=0.05). 
Mucosal thickening was present in 97.4% of 
maxillary sinuses, 80% of anterior ethmoid air cells, 
75.3% of posterior ethmoid air cells, 74.7% of frontal 
sinuses, and 66.3% of sphenoid sinuses. Minimal 
or mild mucosal thickening (score 1) and normally 
aerated sinuses (score 0); corresponded to 71.4% and 
21.3% of all paranasal sinuses, respectively. Marked 
mucosal thickening (score 2) corresponded to 6.9% and 
complete opacification (score 3), 0.4% (Figures 1 and 2). 
No significant difference was observed among the 
paranasal sinuses (Table 2).
The mean score of each paranasal sinus among 
SARS-CoV-2 positive and negative patients was 
0.85±0.27 and 0.87±0.38, respectively (p=0.74).
The median paranasal sinus opacification score for 
each SARS-CoV-2 positive patient was 9 (interquartile 
range – IQR: 8-10) compared to 9 (IQR: 5-10) in 
negative patients (p=0.89). There was no difference in 
mean score adjusted for age and sex. Scores of 13 and 
higher were more frequent in 9/67 (13.4%) SARS-CoV-2 
negative and in only 1/28 (3.6%) positive patients.
The median paranasal sinus score was ten, both 
among patients who reported anosmia/hyposmia (IQR: 
8-11) and among those who did not report this symptom 
(IQR: 7-11; p=0.99) (Table 3).
Air-fluid level was present in 6/28 (21.4%) positive 
patients compared with 14/67 (20.9%) negative patients 
(p=0.95).
Table 2. Modified Lund-Mackay score of paranasal sinuses computed tomography 




0 1 2 3 0 1 2 3
Maxillary 1/3 26/80 1/12 0 0/2 6/82 4/11 0
Ant ethmoid 5/21 23/67 0/7 0 5/17 22/66 1/11 0/1
Post ethmoid 9/26 19/62 0/6 0/1 6/21 22/71 0/3 0
Frontal 5/26 23/66 0/3 0 5/22 22/68 1/4 0/1
Sphenoid 10/33 18/58 0/3 0/1 6/31 20/58 2/6 0
















Air-fluid level Present (%) Absent (%) 
6/20 (30) 22/75 (29.3)
Figure 1. Coronal non-enhanced computed tomography scan of a severe acute 
respiratory syndrome coronavirus 2 positive patient shows normal aeration of the 
paranasal sinuses (score 0)
Figure 2. Coronal non-enhanced computed tomography scan of a severe acute 
respiratory syndrome coronavirus 2 negative patient shows mild mucosal 
thickening of the left maxillary sinus (score 1) and partial opacification (51% to 
99%) of the right maxillary sinus (score 2)
Table 1. Patient characteristics and paranasal sinus computed tomography 
findings by severe acute respiratory syndrome coronavirus 2 polymerase chain 









Age, years 50 (37-62) 52 (44-63) 0.34
Male sex (%) 38 (56.7) 15 (53.6) 0.78
Paranasal sinus opacification score 9 (5-10) 9 (8-10) 0.89
Air-fluid level (%) 14 (20.9) 6 (21.4) 0.95
Nasal obstruction† (%) 1/23 (4.3) 7/17 (41) 0.05
* median (interquartile range - IQR) and Kruskal-Wallis test for age and paranasal sinus opacification score (range 0-30); 
frequency (%) and χ2 test for sex, air-fluid level frequency (%) and Fisher’s exact test for nasal obstruction; † as reported 
by patients who were called by telephone.
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
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Table 3. Median total opacification score in patients with and without recall of 
anosmia/hyposmia
Anosmia p25 p50 p75 Total
Present 8 10 11 7
Absent 7 10 11 33
Median (interquartile range) and Kruskal-Wallis test.
Air-fluid level was present in 6/28 (21.4%) positive 
patients compared with 14/67 (20.9%) negative patients 
(p=0.95).
 ❚ DISCUSSION 
Sinonasal symptoms in SARS-CoV-2 positive patients 
are generally considered to be rare when compared to 
lower respiratory tract symptoms, although variations in 
prevalence (4% to 35% in the case of rhinorrhea) have 
been reported.(1-3) 
Nasal congestion was reported by 41% of SARS-CoV-2 
positive patients, which correlates with the findings of 
Lechien et al.,(4) (36.9%) and Naeini et al.,(5) (32.7%) 
notwithstanding the differences of methodology. 
Few articles have addressed the effect of SARS-CoV-2 
infection on the paranasal sinuses. Chung et al.,(6) 
reported no signs of sinusitis on CT scans of six 
SARS-CoV-2 positive patients who had olfactory 
dysfunction. A recent article included 49 COVID-19 
positive patients with anosmia, used the original Lund-
Mackay scoring system, and showed partial opacification 
in less than 10% of maxillary, frontal and sphenoid 
sinuses, and the ethmoid air cells were normally aerated in 
all patients.(5) In a cohort of 16 COVID-19 positive patients 
with olfactory dysfunction, Lechien et al.,(4) also found 
no significant mucosal thickening of paranasal sinuses, 
with a Lund-Mackay mean score of 0.8. 
Our study included 95 COVID-19 positive and 
negative patients. We decided to use a modified Lund-
Mackay scoring system to better distinguish mild 
mucosal thickening from almost completely opacified 
sinuses. Despite the use of a modified scoring system, 
our findings corroborated the findings of these previous 
studies. We found similar scores for both SARS-CoV-2 
positive and negative patients, with scores zero and one 
being the most common, with a median score of nine 
for both SARS-CoV-2 positive and negative patients 
(out of a maximum score of 30; p=0.89). Indeed, scores 
of 13 or higher were more frequent in SARS-CoV-2 
negative patients. Our findings show that SARS-CoV-2 
infection is not associated with mucosal changes in 
the paranasal sinuses.
There is scarce evidence in the literature regarding 
the effects of common viral respiratory infections in the 
paranasal sinuses. Gwaltney et al.,(7) found opacification 
varying from 87% in the maxillary sinuses to 39% in the 
sphenoid sinuses among patients with common cold. 
Alho,(8) using the Lund-Mckay scoring system, found 
CT mean scores from seven to ten among patients with 
fresh viral cold. Our results are similar to those obtained 
in these articles, both in SARS-CoV-2 positive and 
negative patients.
This was an observational study, therefore prone 
to selection bias if SARS-CoV-2 positive patients were 
more likely to undergo a CT scan for clinical reasons 
related to our outcomes. It also had a relatively small 
sample size which was determined by an 11-week period 
of recruitment rather than on any a priori knowledge 
of possible associations. Nasal congestion was assessed 
by asking participants to recall whether they had this 
symptom at the time of their CT scan, a method which 
is susceptible to recall bias. Clinical data such as the 
average duration of symptoms and the final diagnoses 
of patients who tested negative for SARS-CoV-2 
infection were not available in most cases. Also, we did 
not extract follow-up information on the clinical course 
and eventual outcome of SARS-CoV-2 infection.
 ❚ CONCLUSION
SARS-CoV-2 infection was associated with patient 
recall of nasal congestion, but showed no correlation 
with opacification of paranasal sinuses. 
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